Maxor's Chief Innovation Officer Appointed to Serve on National Association of Specialty Pharmacy Board of Directors

AMARILLO, Texas, Sept. 22, 2017 /PRNewswire/ -- Maxor National Pharmacy Services, LLC (Maxor) today announced that Michael Einodshofer, RPh, MBA, Chief Innovation Officer, has been appointed to serve on the National Association of Specialty Pharmacy (NASP) Board of Directors. The Board of Directors is comprised of a diverse group of specialty pharmacy leaders who share a common passion for serving the needs and improving outcomes of patients with complex and rare diseases.

"I'm thrilled to have the opportunity to serve on this Board to help the future definition and direction of our industry. In many ways, specialty pharmacy is the future of pharmacy," said Einodshofer. "This association, standing together and representing pharmacies nationwide, will work to assure high service, patient focused pharmacies across the country can continue to address the complex needs of our specialty patient populations."

Einodshofer brings over 20 years of involvement in the pharmacy industry, with a focus on the rapidly expanding specialty pharmacy arena. His experience in developing pioneering solutions will facilitate the efforts of the NASP.

"NASP is pleased to welcome Michael Einodshofer to our Board of Directors," said Sheila Arquette, RPh, Executive Director of NASP. "His experience, expertise and commitment to clinical excellence and patient care is unparalleled in our industry. Mike's energy and enthusiasm will be a tremendous asset to our organization."

About NASP
The National Association of Specialty Pharmacy is a 501(c) (6) trade association representing all stakeholders in the specialty pharmacy industry. Members include the nation's leading specialty pharmacies, pharmaceutical and biotechnology manufacturers, GPOs, distributors and more. With over 100 corporate members and 1,200 individuals, NASP is the unified voice of specialty pharmacy in the United States.

About Maxor
Maxor is a leading pharmacy services platform that consists of the following primary business segments: (i) Maxor Specialty, IV Solutions, and Pharmaceutical Specialties, providing specialty pharmacy, respiratory, and home infusion services; (ii) MaxorPlus, providing client and patient focused pharmacy benefit management services; and (iii) Maxor Pharmacy Management and Consulting Services, providing on-site outpatient pharmacy management, 340B audits, and consulting services to health systems, Federally Qualified Health Centers, and employers. More information on Maxor can be found by visiting

View original content with multimedia:

SOURCE Maxor National Pharmacy Services, LLC